BEYONDSPRING Trademark

Trademark Overview

On Friday, August 25, 2017, a trademark application was filed for BEYONDSPRING with the United States Patent and Trademark Office. The USPTO has given the BEYONDSPRING trademark a serial number of 87583965. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Wednesday, December 18, 2024. This trademark is owned by BeyondSpring Pharmaceuticals, Inc.. The BEYONDSPRING trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, anti-inflammatories; pharmaceuticals, medications and preparations for the prevention and treatment of skin conditions, cancer and disorders of the nervous, immune and pulmonary systems; medical vials and other such containers filled with pharmaceutical preparations for treatment of skin conditions, cancer and disorders of the nervous, immune and pulmonary systems

Pharmaceutical research; medical, scientific and pharmaceutical research in the field of skin treatment, cancer and the nervous, immune and pulmonary systems; biological research; research and development of new pharmaceutical, and life science products; chemical research; biology research
beyondspring

General Information

Serial Number87583965
Word MarkBEYONDSPRING
Filing DateFriday, August 25, 2017
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateWednesday, December 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements

Goods and ServicesPharmaceuticals, namely, anti-inflammatories; pharmaceuticals, medications and preparations for the prevention and treatment of skin conditions, cancer and disorders of the nervous, immune and pulmonary systems; medical vials and other such containers filled with pharmaceutical preparations for treatment of skin conditions, cancer and disorders of the nervous, immune and pulmonary systems
Goods and ServicesPharmaceutical research; medical, scientific and pharmaceutical research in the field of skin treatment, cancer and the nervous, immune and pulmonary systems; biological research; research and development of new pharmaceutical, and life science products; chemical research; biology research

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 24, 2018
Primary Code005
First Use Anywhere DateWednesday, April 20, 2022
First Use In Commerce DateWednesday, April 20, 2022
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 24, 2018
Primary Code042
First Use Anywhere DateFriday, March 31, 2017
First Use In Commerce DateFriday, March 31, 2017

Trademark Owner History

Party NameBeyondSpring Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932
Party NameBeyondSpring Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10005

Trademark Events

Event DateEvent Description
Tuesday, August 29, 2017TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, August 29, 2017NEW APPLICATION ENTERED
Tuesday, August 29, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 29, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, August 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 30, 2017ASSIGNED TO EXAMINER
Monday, December 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2017NON-FINAL ACTION E-MAILED
Monday, December 4, 2017NON-FINAL ACTION WRITTEN
Wednesday, May 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 8, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 6, 2018SUSPENSION LETTER WRITTEN
Wednesday, June 6, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, June 6, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 16, 2019ASSIGNED TO LIE
Wednesday, January 16, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, September 25, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 3, 2020NON-FINAL ACTION WRITTEN
Thursday, December 3, 2020NON-FINAL ACTION E-MAILED
Thursday, December 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 4, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 1, 2022SOU EXTENSION 2 FILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 1, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 1, 2022SOU EXTENSION 1 FILED
Friday, April 1, 2022SOU EXTENSION 1 GRANTED
Tuesday, April 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 1, 2022SOU EXTENSION 2 GRANTED
Wednesday, April 5, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 5, 2023SOU EXTENSION 3 FILED
Wednesday, April 5, 2023SOU EXTENSION 3 GRANTED
Friday, September 22, 2023SOU EXTENSION 4 FILED
Friday, September 22, 2023SOU EXTENSION 4 GRANTED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU EXTENSION 5 FILED
Monday, October 7, 2024USE AMENDMENT FILED
Monday, October 7, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, December 18, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 18, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU EXTENSION 5 GRANTED

Related Keywords

beyondspring research pharmaceutical skin nervous cancer treatment pulmonary systems immune pharmaceuticals